Garcia Marino — SEC Form 4 filings
SEC reporting owner CIK 1669866. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-26 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 2 filings — 288,918 shares, $27,961,832 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 104,091 shares @ $107.96 ($11,237,664) in Dianthus Therapeutics, Inc. /DE/, filed 2026-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT, Director | 8 | — | 12 legs · 288,918 sh · $27,961,832 | 15 |
| AgomAb Therapeutics NV (AGMB) | Director | 1 | — | — | 1 |
Form 4 filings — Garcia Marino
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | AgomAb Therapeutics NV (AGMB) | Grant/award (A): 57,482 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 40,000 @ $8.44 · Option exercise (M): 126,000 @ $8.44 · Sale (S): 10,384 @ $107.49 · Sale (S): 23,907 @ $108.05 · Sale (S): 2,373 @ $109.10 · Sale (S): 2,536 @ $110.02 · +5 more | EDGAR |
| 2026-03-17 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 59,700 @ $6.70 · Option exercise (M): 5,592 @ $17.88 · Option exercise (M): 59,700 (derivative) @ $0 · Option exercise (M): 5,592 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 122,918 @ $6.70 · Sale (S): 43,505 @ $80.69 · Sale (S): 65,517 @ $81.74 · Sale (S): 12,796 @ $82.60 · Sale (S): 200 @ $83.38 · Sale (S): 900 @ $85.53 · +1 more | EDGAR |
| 2026-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 355,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 340,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 243,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1669866 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →